On this page:

News Release

Listen

NHS drugs supply

29/10/2009

The Scottish Government has reached settlement with a pharmaceutical company over alleged anti-competitive behaviour in the supply of drugs to the NHS.

OPD Cartons Limited (formerly Kent Pharmaceuticals Limited) has agreed, on a full and final basis, to pay £225,000 in compensation.

Cabinet Secretary for Health and Wellbeing, Nicola Sturgeon, said: "I am pleased that our discussions with Kent have been concluded on a positive note and have resulted in a satisfactory settlement."

Peter MacIntyre, Interim Head of Service at NHS Scotland Counter Fraud Services, added: "This outcome is a welcome one and I am glad that the CFS has played a role in this."

In February 2005, the Scottish Ministers and Scottish Health Boards lodged claims in the civil courts in England against a number of companies, in connection with forming alleged price-fixing cartels in respect of the following generic drugs - Warfarin, Ranitidine and Penicillin-based drugs.

Previous without admission of liability settlements:

1. The Goldshield Group Plc, Goldshield Pharmaceuticals Ltd and Forley Generics Ltd (£750,000)

2. Norton Healthcare Limited and Norton Pharmaceuticals Limited (£2,837,500)

3. Generics (UK) Ltd (£2.31million)

4. Ranbaxy (UK) Ltd (£1,057,500)

Page updated: Thursday, October 29, 2009